<DOC>
	<DOC>NCT00044005</DOC>
	<brief_summary>The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with schizophrenia.</brief_summary>
	<brief_title>Safety and Tolerability Study of Drug to Treat Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>Inclusion criteria: Successful completion of participation in protocol #D1050049 Exclusion criteria: Substance abuse Prolactin level of â‰¥200ng/mL at baseline Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Latuda</keyword>
	<keyword>Lurasidone</keyword>
</DOC>